期刊文献+

帕罗西汀合并小剂量奎硫平治疗广泛性焦虑症临床对照研究 被引量:3

Efficacy of Small-dose Quetiapine in the Treatment of Generalized Anxiety Disorder.
原文传递
导出
摘要 目的探讨小剂量奎硫平在治疗广泛性焦虑症中的疗效和副作用。方法将70例广泛性焦虑症患者随机分为单用组(单用帕罗西汀)和合用组(帕罗西汀合用奎硫平)。疗程6周。采用汉密尔顿焦虑量表(HAMA)和副反应量表(TESS)评定疗效及副反应。结果①两组治疗后HAMA评分均较治疗前明显下降(P均<0.01);两组间比较,合用组起效快,治疗第1、4、6周末,合用组HAMA评分显著低于单用组(P均<0.05);②合用组疗效优于单用组,但在第6周末疗效差异无统计学意义(χ2=3.99,P>0.05);③两组不良反应比较无明显差异(χ2=1.08,P>0.05)。结论帕罗西汀合用小剂量奎硫平治疗广泛性焦虑症起效快,可增加疗效,安全性好。 Objective To study the efficacy and safety of small-dose quetiapine in the treatment of generalized anxiety disorder.Methods A total of 70 patients with generalized anxiety disorder were randomly assigned to the group which paroxetine combined with quetiapine and control group(paroxetine only) for 6 weeks.Hamilton anxiety scale(HAMA) and treatment emergent symptom scale(TESS) were used to evaluate the clinical efficacy and safety.Results ①The score of HAMA reduced significantly after treatment in two groups(both P〈0.01),with markedly lower score of HAMA in combined group in 1st,4th and 6th weeks treatment when compared to that in control group(both P〈0.05).②No significant difference was found in the curative effects between the two groups at the end of 6 weeks(χ^2=3.99,P〉0.05).③There was no significant difference in adverse effects between the two groups(χ^2=1.08,P〉0.05).Conclusion Paroxetine combined with quetiapine in the treatment of generalized anxiety disorder may augment the treatment effect and has a better safety.
作者 汪周兵 徐星
出处 《中国健康心理学杂志》 2010年第11期1289-1290,共2页 China Journal of Health Psychology
关键词 奎硫平 帕罗西汀 广泛性焦虑症 疗效 副作用 Quetiapine Paroxetine Generalized anxiety disorder Efficacy Side effect
  • 相关文献

参考文献7

二级参考文献36

  • 1仲崇丽,崔永华.奎硫平对精神分裂症患者生活质量的影响[J].临床精神医学杂志,2005,15(2):103-105. 被引量:23
  • 2Gefvert O, Lundberg T, Wieselgren IM, et al. D2 and 5HT2A receptor occupancy of different doses of quuetiapine in Schizophrenia: a PET study. Eur Neuropsychopharmacol. 2001;11:105-110.
  • 3Goldslein J, Arvanitis L: ICI 204, 636 (seroquel): a dibenothiazepine atypical antipsychotic: review of preclinical pharmacology and highlights of phase 2 clinical trials. CNS Drug Rev. 1995; 1: 50-73.
  • 4Kapur S, Seeman P: Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotic? : a new hypothesis. Am J Psychiatry, 2001; 158: 360-369.
  • 5Arvanitis LA, Miller BG: The Seroquel Trial 13 Study Group.Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation oi" schizophrenia: a comparison with haloperidol and placebo. Biol Psychiatry, 1997 ; 42: 233-246.
  • 6Chan-Ob T, Kuntawongse N, Boonymaaruthee V: Quetiapine for tic disorder: a case report. J Med Assoc Thai. 2001 ; 84:1624-1628.
  • 7Parraga HC, Parraga MI, Woodward RL, et al: Quetiapine treatment of children with Tourette' s syndrome: report of two cases. J Child Adolesc: psychopharmacol. 2001 ; 11 : 187-191.
  • 8Targum SD, Abbott JL: Psychoses in the elderly: a spectrum of disorders. J Clin Psychiatry, 1999; 60 (Suppl 8) : 4-10.
  • 9Byerly MJ, Weber MT, Brooks DL, et al. Antipsychotic medications and the elderly: effects on cognition and implications for use. Drugs Aging, 2001; 18: 45-61.
  • 10Tariot P, Schneider L, Katz IR, et al. Quetiapine in nursing home residents with Alzheimer' s dementia and psychosis[ poster]. Presented at the 15th annual meeting of the American Association for Geriatric Psychiatry; Feb 24-27, 2002; Orlando, Fla.

共引文献201

同被引文献12

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部